JP2006515585A5 - - Google Patents

Download PDF

Info

Publication number
JP2006515585A5
JP2006515585A5 JP2004559375A JP2004559375A JP2006515585A5 JP 2006515585 A5 JP2006515585 A5 JP 2006515585A5 JP 2004559375 A JP2004559375 A JP 2004559375A JP 2004559375 A JP2004559375 A JP 2004559375A JP 2006515585 A5 JP2006515585 A5 JP 2006515585A5
Authority
JP
Japan
Prior art keywords
pyridyl
group
alkyl
compound
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004559375A
Other languages
English (en)
Japanese (ja)
Other versions
JP4903385B2 (ja
JP2006515585A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/038834 external-priority patent/WO2004052291A2/en
Publication of JP2006515585A publication Critical patent/JP2006515585A/ja
Publication of JP2006515585A5 publication Critical patent/JP2006515585A5/ja
Application granted granted Critical
Publication of JP4903385B2 publication Critical patent/JP4903385B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2004559375A 2002-12-06 2003-12-05 損傷した哺乳類神経組織を治療するためのピリジン類 Expired - Fee Related JP4903385B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US43163702P 2002-12-06 2002-12-06
US60/431,637 2002-12-06
PCT/US2003/038834 WO2004052291A2 (en) 2002-12-06 2003-12-05 Pyridines for treating injured mammalian nerve tissue

Publications (3)

Publication Number Publication Date
JP2006515585A JP2006515585A (ja) 2006-06-01
JP2006515585A5 true JP2006515585A5 (enExample) 2007-02-01
JP4903385B2 JP4903385B2 (ja) 2012-03-28

Family

ID=32507771

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004559375A Expired - Fee Related JP4903385B2 (ja) 2002-12-06 2003-12-05 損傷した哺乳類神経組織を治療するためのピリジン類

Country Status (9)

Country Link
US (2) US7244748B2 (enExample)
EP (1) EP1567497B1 (enExample)
JP (1) JP4903385B2 (enExample)
CN (1) CN1745064A (enExample)
AT (1) ATE443699T1 (enExample)
AU (1) AU2003298034B2 (enExample)
CA (1) CA2508165C (enExample)
DE (1) DE60329415D1 (enExample)
WO (1) WO2004052291A2 (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8729107B2 (en) * 2002-12-06 2014-05-20 Purdue Research Foundation Pyridines for treating injured mammalian nerve tissue
FR2849029B1 (fr) 2002-12-20 2005-03-18 Lafon Labor Procede de preparation et formes cristallines des enantiomeres optiques du modafinil.
WO2007061554A2 (en) * 2005-10-21 2007-05-31 Purdue Research Foundation Dosage of 4-aminopyridine derivatives for treatment of central nervous system injuries
US8066306B1 (en) 2008-07-18 2011-11-29 Chicago Tag & Label, Inc. Label sheet with wristband
US8181994B1 (en) 2008-07-18 2012-05-22 Chicago Tag & Label, Inc. Sheet with wristband
WO2012009204A1 (en) * 2010-07-15 2012-01-19 The Trustees Of Columbia University In The City Of New York Methods for diagnosing and treating concussive disorders
WO2012088266A2 (en) 2010-12-22 2012-06-28 Incyte Corporation Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
EP2850044B1 (en) * 2012-05-17 2017-05-17 The University of Chicago Use of fluorinated derivatives of 4-aminopyridine in therapeutics and medical imaging
US9617215B2 (en) 2012-05-17 2017-04-11 The University Of Chicago Use of fluorinated derivatives of 4-aminopyridine in therapeutics and medical imaging
CN102702261A (zh) * 2012-05-29 2012-10-03 南京信息工程大学 制备1-取代苯基-4-乙氧羰基-5-( 二苯基膦氧)氨基-1 ,2 ,3-三唑的方法
ES2984771T3 (es) 2012-06-13 2024-10-31 Incyte Holdings Corp Compuestos tricíclicos sustituidos como inhibidores de FGFR
WO2014026125A1 (en) 2012-08-10 2014-02-13 Incyte Corporation Pyrazine derivatives as fgfr inhibitors
US9266892B2 (en) 2012-12-19 2016-02-23 Incyte Holdings Corporation Fused pyrazoles as FGFR inhibitors
EA035095B1 (ru) 2013-04-19 2020-04-27 Инсайт Холдингс Корпорейшн Бициклические гетероциклы в качестве ингибиторов fgfr
US10851105B2 (en) 2014-10-22 2020-12-01 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
US9580423B2 (en) 2015-02-20 2017-02-28 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
MA41551A (fr) 2015-02-20 2017-12-26 Incyte Corp Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4
EA038045B1 (ru) 2015-02-20 2021-06-28 Инсайт Корпорейшн Бициклические гетероциклы в качестве ингибиторов fgfr
AR111960A1 (es) 2017-05-26 2019-09-04 Incyte Corp Formas cristalinas de un inhibidor de fgfr y procesos para su preparación
RS66310B1 (sr) 2018-05-04 2025-01-31 Incyte Corp Čvrsti oblici inhibitora fgfr i procesi za njegovu pripremu
US11174257B2 (en) 2018-05-04 2021-11-16 Incyte Corporation Salts of an FGFR inhibitor
WO2020185532A1 (en) 2019-03-08 2020-09-17 Incyte Corporation Methods of treating cancer with an fgfr inhibitor
WO2021007269A1 (en) 2019-07-09 2021-01-14 Incyte Corporation Bicyclic heterocycles as fgfr inhibitors
WO2021067374A1 (en) 2019-10-01 2021-04-08 Incyte Corporation Bicyclic heterocycles as fgfr inhibitors
PH12022550892A1 (en) 2019-10-14 2023-05-03 Incyte Corp Bicyclic heterocycles as fgfr inhibitors
US11566028B2 (en) 2019-10-16 2023-01-31 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors
AU2020395185A1 (en) 2019-12-04 2022-06-02 Incyte Corporation Derivatives of an FGFR inhibitor
EP4069696A1 (en) 2019-12-04 2022-10-12 Incyte Corporation Tricyclic heterocycles as fgfr inhibitors
US12012409B2 (en) 2020-01-15 2024-06-18 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors
JP2024513575A (ja) 2021-04-12 2024-03-26 インサイト・コーポレイション Ｆｇｆｒ阻害剤及びネクチン－４標的化剤を含む併用療法
WO2022261160A1 (en) 2021-06-09 2022-12-15 Incyte Corporation Tricyclic heterocycles as fgfr inhibitors
TW202313610A (zh) 2021-06-09 2023-04-01 美商英塞特公司 作為ｆｇｆｒ抑制劑之三環雜環

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1071035A (en) * 1964-09-02 1967-06-07 Rech Et Pharmacologie Improvements in and relating to new carbamates and thiocarbamates and the process of preparation and therapeutic applications thereof
US3433873A (en) * 1966-04-05 1969-03-18 Phillips Petroleum Co Compositions and methods for controlling birds
US3804844A (en) * 1970-12-02 1974-04-16 Dow Chemical Co Process for preparing pyridylcarbamates
GB1339764A (en) * 1971-03-29 1973-12-05 Ici Ltd Pyridine derivatives
IE36221B1 (en) * 1971-04-21 1976-09-15 Ciba Geigy Ag Acylamino compounds and a process for their manufacture
SU464177A1 (ru) * 1973-01-08 1978-03-25 Донецкое Отделение Физико-Органической Химии Института Физической Химии Ан Украинской Сср Способ получени 4-галоидзамещенных имидазо- (4,5-с)-пиридин -2-она
US3995042A (en) 1973-09-07 1976-11-30 E. R. Squibb & Sons, Inc. Pyridine containing compounds
US4304911A (en) * 1980-11-19 1981-12-08 Sterling Drug Inc. Benzoylphenyl lower alkanoyl piperidines
FR2624699B1 (fr) * 1987-12-18 1990-04-13 Bernard Lyon I Universite Clau Derives heterocycliques de n-carbamoyl-, n-thiocarbamoyl- ou n-amidino-glycine ou beta-alanine utiles comme agents edulcorants
JPH03181462A (ja) * 1989-12-08 1991-08-07 Nippon Kayaku Co Ltd Ｎ―（４―ピリジル）カーバメート誘導体およびそれを有効成分とする開花促進剤
IE82916B1 (en) 1990-11-02 2003-06-11 Elan Corp Plc Formulations and their use in the treatment of neurological diseases
AU677968B2 (en) * 1992-09-25 1997-05-15 H. Lundbeck A/S DNA encoding human alpha 1 adrenergic receptors and uses thereof
CA2085785C (en) 1992-12-18 2005-03-15 Robert R. Hansebout The use of 4-aminopyridine in the treatment of a neurological condition
US5502498A (en) 1993-03-10 1996-03-26 Samsung Electronics Co., Ltd. Clamp signal generation-control circuit and a method therefor
ES2134491T3 (es) 1994-09-22 1999-10-01 Yukong Ltd Nuevos compuestos de carbamato y procedimientos para su preparacion.
JP3583489B2 (ja) 1994-12-22 2004-11-04 日清紡績株式会社 カルボジイミド誘導体
ATE182585T1 (de) * 1995-04-28 1999-08-15 Kumiai Chemical Industry Co Pyridinderivative und pestizide
US5880128A (en) * 1996-05-08 1999-03-09 Schering Corporation Carbonyl piperazinyl and piperidinyl compounds
ATE256126T1 (de) 1996-10-07 2003-12-15 Ortho Mcneil Pharm Inc 5-heteroatom-alkyl substituierte 3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid derivate zur behandlung zentral nervöser system störungen
US5961309A (en) * 1997-04-24 1999-10-05 Trw Inc. Gear pump with noise attenuation
WO1999018104A1 (en) 1997-10-07 1999-04-15 Ortho-Mcneil Pharmaceutical, Inc. Naphtho-imidazo[1,2-a]pyridine derivatives, their preparation and their use in treating central nervous system disorders
US6632823B1 (en) 1997-12-22 2003-10-14 Merck & Co., Inc. Substituted pyridine compounds useful as modulators of acetylcholine receptors
AUPP150098A0 (en) * 1998-01-27 1998-02-19 Fujisawa Pharmaceutical Co., Ltd. Benzamide derivatives
EP1066286B1 (en) * 1998-03-04 2009-04-29 Bristol-Myers Squibb Company Heterocyclo-substituted imidazopyrazine protein tyrosine kinase inhibitors
ATE258934T1 (de) * 1998-10-30 2004-02-15 Lilly Co Eli Azaindol derivate und ihre verwendung als antithrombotische wirkstoffe
DK1394150T3 (da) 1999-02-24 2011-03-21 Hoffmann La Roche 4-phenylpyridinderivater og deres anvendelse som NK-1-receptorantagonister
CZ20013036A3 (cs) 1999-02-25 2002-03-13 Pfizer Products Inc. 2-aminopyridiny obsahující jako substituenty kondenzované kruhové skupiny
EP1165555B1 (en) * 1999-03-11 2003-07-16 Neurogen Corporation Aryl fused 2,4-disubstituted pyridines: nk3 receptor ligands
CZ2002323A3 (cs) * 1999-07-28 2002-05-15 Aventis Pharmaceuticals Products Inc. Substituované oxoazaheterocyklylové sloučeniny a farmaceutické prostředky, které je obsahují
US6495550B2 (en) 1999-08-04 2002-12-17 Icagen, Inc. Pyridine-substituted benzanilides as potassium ion channel openers
WO2001034567A1 (en) * 1999-11-10 2001-05-17 Aventis Pharma Deutschland Gmbh N-acylpyrrolidin-2-ylalkylbenzamidine derivatives as inhibitors of factor xa
FR2806722B1 (fr) * 2000-03-23 2002-05-17 Sanofi Synthelabo Derives de n-(heterocyclylbutyl) benzene-ou pyridine sulfonamide, leur preparation et leur application en therapeutique
US20020045613A1 (en) * 2000-04-27 2002-04-18 Heinz Pauls 1-aroyl-piperidinyl benzamidines
DE10063294A1 (de) 2000-12-19 2002-07-04 Aventis Pharma Gmbh Substituierte Heterocyclo-Norbornylamino-Derivate, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
SK14142003A3 (sk) 2001-05-31 2005-03-04 Sanofi-Aventis Aminochinolínové a aminopyridínové deriváty a ich použitie ako adenozínových A3 ligandov
JP2003073357A (ja) * 2001-09-03 2003-03-12 Mitsubishi Pharma Corp アミド化合物を含有するＲｈｏキナーゼ阻害剤
AR037211A1 (es) * 2001-11-07 2004-10-27 Schering Corp Derivados de heteroarilo como ligandos superiores para el receptor de nociceptina orl-1

Similar Documents

Publication Publication Date Title
JP2006515585A5 (enExample)
US12037321B2 (en) 1,2,4-oxadiazole derivatives as immunomodulators
DE60021254T2 (de) N-cyanomethylamide als protease inhibitoren
CN1118458C (zh) 作为白细胞介素抑制剂的嘧啶基衍生物
JP2005519932A5 (enExample)
JP2013525318A5 (enExample)
PL174617B1 (pl) Nowe związki, pochodne iperytu azotowego i aminokwasu oraz sposób ich wytwarzania
JP2003513002A5 (enExample)
JP2011520815A5 (enExample)
EP3022174B1 (en) Derivatives of n-urea substituted amino acids as formyl peptide receptor modulators
KR20050036983A (ko) 아릴 및 헤테로아릴 프로펜 아미드, 이들의 유도체 및 이의치료학적 용도
JP2007526257A5 (enExample)
HU211704A9 (en) Pyridinium derivatives, their production and use
RU2007106935A (ru) Производные гуанидина и их терапевтическое применение
RU2012127709A (ru) Пирувамидные соединения в качестве ингибиторов аллергена пылевых клещей 1 группы, представляющего собой пептидазу, и их применение
JP2006508090A5 (enExample)
JP2004536853A5 (enExample)
RU2001102266A (ru) Амидино- и гуанидиноазетидиноны-ингибиторы триптазы
JP2005514440A5 (enExample)
RU2007112501A (ru) Бензимидазольные производные, содержащие их композиции, их получение и применение
HK1039116A1 (zh) 用作細胞增殖抑制劑的氰基胍化合物
JP2008540443A5 (enExample)
CN1390228A (zh) 口服活性a1腺苷受体激动剂
JP2006500372A5 (enExample)
CN1308534A (zh) 血管生成抑制剂